Apyx Medical Corp (APYX) income statement
APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3018% above fair value
$2.56−0.09 (-3.58%)
Close on Nov 17, 2026Market cap $107.63MP/E –Yield –
Apyx Medical Corp income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 63.5%
- Operating margin
- -6.1%
- Net margin
- -14.8%
- Return on equity, FY2025
- -78.0%
Financial strength
- Current ratio
- 5.68
- Debt to equity
- 3.31
- Debt to assets
- 57.8%
- Cash to current liabilities
- 295.2%
Valuation
- P/E ratio
- –
- Price to sales
- 1.84
- Price to book
- 10.09
- Dividend yield
- –
See a number that looks wrong?